BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2978501)

  • 1. Efficacy of enoximone in the management of refractory low output states following cardiac surgery.
    Gonzalez M; Desager JP; Jacquemart JL; Chenu P; Muller T; Installé E
    Br J Clin Pract Suppl; 1988 Dec; 64():53-64. PubMed ID: 2978501
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of a new inotropic agent, enoximone, in heart surgery].
    Gomar C; Fita G; Pomar JL; Valero R; Mulet J; Nalda MA
    Rev Esp Anestesiol Reanim; 1991; 38(2):121-6. PubMed ID: 1678896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enoximone, a pharmacological bridge to transplantation.
    Dubois-Randé JL; Loisance D; Duval AM; Deleuze P; Lellouche D; Hillion ML; Tarral A; Castaigne A
    Br J Clin Pract Suppl; 1988 Dec; 64():73-9. PubMed ID: 2978504
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of enoximone and dobutamine on hemodynamic performance after open heart surgery. A clinical comparison.
    Zeplin HE; Dieterich HA; Stegmann T
    J Cardiovasc Surg (Torino); 1990; 31(5):574-7. PubMed ID: 2146272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of enoximone in patients awaiting cardiac transplant.
    Bristow MR; Lee HE; Gilbert EM; Renlund DG; Hegewald MG; Hershberger RE; O'Connell JB
    Br J Clin Pract Suppl; 1988 Dec; 64():69-72. PubMed ID: 2978503
    [No Abstract]   [Full Text] [Related]  

  • 6. Enoximone in heart failure: mechanisms of action.
    Chatterjee K
    Br J Clin Pract Suppl; 1988 Dec; 64():19-25. PubMed ID: 2978496
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of enoximone in the management of refractory low-output states following cardiac surgery.
    Gonzalez M; Desager JP; Jacquemart JL; Chenu P; Muller T; Installé E
    J Cardiothorac Anesth; 1988 Aug; 2(4):409-18. PubMed ID: 17171924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of low cardiac output syndrome after cardiac surgery using enoximone.
    White DA; Latimer RD; Oduro A
    Anaesthesia; 1990 May; 45(5):386-9. PubMed ID: 2141451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enoximone in low output syndrome during the perioperative period of cardiac surgery].
    Guarneri S; Cavaliere F; Rossi M; Martinelli L; Zamparelli R; Schiavello R
    Minerva Anestesiol; 1991 Oct; 57(10):1034-5. PubMed ID: 1835766
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of cardiovascular effects of dobutamine and enoximone in treatment of low cardiac output syndrome after valvular surgery--preliminary results.
    George M; Lehot JJ; Bastien O; Durand PG; Estanove S
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):12. PubMed ID: 2535301
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of enoximone in weaning from cardiopulmonary bypass following mitral valve surgery.
    Tarr TJ; Jeffrey RR; Kent AP; Cowen ME
    Cardiology; 1990; 77 Suppl 3():51-7; discussion 62-7. PubMed ID: 2148281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with phosphodiesterase inhibitors in paediatric cardiac surgery.
    Hausdorf G
    Eur J Anaesthesiol Suppl; 1993; 8():25-30. PubMed ID: 8223352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enoximone in the treatment of postoperative low cardiac output syndrome in pediatric heart surgery. Open study in tetralogy of Fallot].
    Cossolini M; Ferri F; Giupponi A; Valoti O; Veritti U
    Minerva Anestesiol; 1997 Jun; 63(6):213-9. PubMed ID: 9411285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of haemodynamic efficacy of enoximone and dobutamine in coronary surgery patients.
    Boldt J; Dieterich HA; Hempelmann G
    Br J Clin Pract Suppl; 1988 Dec; 64():41-5. PubMed ID: 2978499
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment with phosphodiesterase inhibitors: Contra].
    Löllgen H; Fahrenkrog U
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1992 Aug; 27(5):322-4. PubMed ID: 1391373
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment with phosphodiesterase inhibitors: Pro].
    Boldt J; Knothe C; Hempelmann G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1992 Aug; 27(5):319-21. PubMed ID: 1391372
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of enoximone in patients with cardiac failure after myocardial infarction.
    Renard M; Dereppe H; Henuzet C; Stevens E; Bernard R
    Br J Clin Pract Suppl; 1988 Dec; 64():37-40. PubMed ID: 2978498
    [No Abstract]   [Full Text] [Related]  

  • 18. Enoximone in newborns with refractory postoperative low-output states (LOS).
    Hausdorf G; Friedel N; Berdjis F; Dieterich HA; Fell JJ; Dressler HT; Werneyer A; Hetzer R; Lange PE
    Eur J Cardiothorac Surg; 1992; 6(6):311-7. PubMed ID: 1535503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phosphodiesterase-inhibitor enoximone--a new concept in the therapy of patients with impaired myocardial function in cardiac surgery.
    Boldt J; Kling D; Hempelmann G
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):10. PubMed ID: 2535299
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of low cardiac output syndrome in newborn infants and children].
    Hausdorf G; Loebe M
    Z Kardiol; 1994; 83 Suppl 2():91-100. PubMed ID: 8091831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.